{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:39:58Z","timestamp":1779147598394,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.exer.2021.108825","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T21:50:26Z","timestamp":1635889826000},"page":"108825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Topical neurokinin-1 receptor antagonist Fosaprepitant ameliorates ocular graft-versus-host disease in a preclinical mouse model"],"prefix":"10.1016","volume":"212","author":[{"given":"Romina Mayra","family":"Lasagni Vitar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Bonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u00e7a","family":"Atay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Triani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Fonteyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Di Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Rama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0833-6927","authenticated-orcid":false,"given":"Anna","family":"Mondino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2021.108825_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/1523-1747.ep12330326","article-title":"Skin-nervous system interactions","volume":"106","author":"Ansel","year":"1996","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.exer.2021.108825_bib2","doi-asserted-by":"crossref","first-page":"15437","DOI":"10.18632\/oncotarget.24602","article-title":"The glucocorticoid receptor in recipient cells keeps cytokine secretion in acute graft-versus-host disease at bay","volume":"9","author":"Baake","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.exer.2021.108825_bib3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1167\/iovs.17-23198","article-title":"Substance P modulation of human and murine corneal neovascularization","volume":"59","author":"Barbariga","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108825_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00163","article-title":"The role of regulatory T cells in the biology of graft versus host disease","volume":"4","author":"Beres","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2021.108825_bib5","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1167\/iovs.14-14553","article-title":"NK1 receptor antagonists as a new treatment for corneal neovascularization","volume":"55","author":"Bignami","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108825_bib6","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1111\/aos.13304","article-title":"Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment","volume":"95","author":"Bignami","year":"2017","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2021.108825_bib7","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2174\/1389450116666151019100216","article-title":"Substance P and its inhibition in ocular inflammation","volume":"17","author":"Bignami","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.exer.2021.108825_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105896","article-title":"Modified extracorporeal photopheresis with cells from a healthy donor for acute graft-versus-host disease in a mouse model","volume":"9","author":"Budde","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2021.108825_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/vox.12723","article-title":"An alternative for extracorporeal photopheresis: 8-methoxypsoralen and UVA-treated leucocytes from allogeneic donors improve graft-versus-host disease in mice","volume":"113","author":"Budde","year":"2018","journal-title":"Vox Sang."},{"key":"10.1016\/j.exer.2021.108825_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00277-015-2565-y","article-title":"Dendritic polyglycerol sulfate attenuates murine graft-versus-host disease","volume":"95","author":"Budde","year":"2016","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.exer.2021.108825_bib11","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.4049\/jimmunol.148.11.3498","article-title":"Substance P enhances IL-2 expression in activated human T cells","volume":"148","author":"Calvo","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.exer.2021.108825_bib12","first-page":"425","article-title":"Cyclosporine A for the prevention of ocular graft versus host disease in allogeneic hematopoietic stem cell transplant recipients is safe and feasible","volume":"143","author":"Cant\u00fa-Rodr\u00edguez","year":"2020","journal-title":"AHA"},{"key":"10.1016\/j.exer.2021.108825_bib13","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1089\/jop.2018.0006","article-title":"Topical cyclosporine pretreatment of ocular surface in allogeneic hematopoietic stem cell transplant recipients","volume":"34","author":"Chun","year":"2018","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.exer.2021.108825_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ICO.0b013e318226bf97","article-title":"Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD","volume":"31","author":"Dietrich-Ntoukas","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2021.108825_bib15","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00417-013-2301-z","article-title":"Graft versus host disease: clinical evaluation, diagnosis and management","volume":"251","author":"Espana","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108825_bib16","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2021.108825_bib17","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1167\/iovs.12-10782","article-title":"Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring","volume":"54","author":"Ferrari","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108825_bib18","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00417-019-04301-6","article-title":"Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle","volume":"257","author":"Giannaccare","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108825_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1357-2725(01)00031-0","article-title":"Substance P","volume":"33","author":"Harrison","year":"2001","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.exer.2021.108825_bib20","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1167\/iovs.05-0040","article-title":"Lacrimal gland involvement in graft-versus-host disease: a murine model","volume":"46","author":"Hassan","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108825_bib21","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1167\/iovs.14-15630","article-title":"Recruitment of donor T cells to the eyes during ocular GVHD in recipients of MHC-matched allogeneic hematopoietic stem cell transplants","volume":"56","author":"Herretes","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108825_bib22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/ACI.0b013e328357b4b9","article-title":"Ocular graft-versus-host disease","volume":"12","author":"Hessen","year":"2012","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.exer.2021.108825_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.exer.2021.108825_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2018.02.012","article-title":"Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity","volume":"109","author":"Karin","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.exer.2021.108825_bib25","first-page":"367","article-title":"Tear production rate in a mouse model of dry eye according to the phenol red thread and endodontic absorbent paper point tear tests","volume":"66","author":"Kilic","year":"2016","journal-title":"Comp. Med."},{"key":"10.1016\/j.exer.2021.108825_bib26","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/1523-1747.ep12462082","article-title":"Structure, functions, and mechanisms of substance P receptor action","volume":"98","author":"Krause","year":"1992","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.exer.2021.108825_bib27","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<3815::AID-IMMU3815>3.0.CO;2-#","article-title":"Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation","volume":"29","author":"Lambrecht","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.exer.2021.108825_bib28","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1096\/fj.201903236R","article-title":"Sensory neurons directly promote angiogenesis in response to inflammation via substance P signaling","volume":"34","author":"Liu","year":"2020","journal-title":"Faseb. J."},{"key":"10.1016\/j.exer.2021.108825_bib29","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1158\/1078-0432.CCR-19-1344","article-title":"Cisplatin facilitates radiation-induced abscopal effects in conjunction with PD-1 checkpoint blockade through CXCR3\/CXCL10-mediated T-cell recruitment","volume":"25","author":"Luo","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.exer.2021.108825_bib30","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/ICO.0b013e3181e456f0","article-title":"Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05","volume":"29","author":"Malta","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2021.108825_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.exer.2016.11.004","article-title":"Assessment of dry eye in a GVHD murine model: approximation through tear osmolarity measurement","volume":"154","author":"Mart\u00ednez-Carrasco","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108825_bib32","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1007\/s00018-016-2293-z","article-title":"Neuropeptide substance P and the immune response","volume":"73","author":"Mashaghi","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.exer.2021.108825_bib33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/1523-1747.ep12874665","article-title":"Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium","volume":"94","author":"Matis","year":"1990","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.exer.2021.108825_bib34","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1097\/CCM.0000000000002075","article-title":"Antagonism of the neurokinin-1 receptor improves survival in a mouse model of sepsis by decreasing inflammation and increasing early cardiovascular function","volume":"45","author":"Mella","year":"2017","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.exer.2021.108825_bib35","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.celrep.2020.02.054","article-title":"Neurokinin-1 receptor signaling is required for efficient Ca2+ flux in T-cell-receptor-activated T cells","volume":"30","author":"Morelli","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.exer.2021.108825_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/OPX.0000000000001071","article-title":"A review of ocular graft-versus-host disease","volume":"94","author":"Munir","year":"2017","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108825_bib37","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00726-014-1736-9","article-title":"Involvement of substance P and the NK-1 receptor in human pathology","volume":"46","author":"Mu\u00f1oz","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.exer.2021.108825_bib38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.sjopt.2013.06.007","article-title":"Ocular manifestations of graft-versus-host disease","volume":"27","author":"Nassar","year":"2013","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.exer.2021.108825_bib39","article-title":"Role of substance P in the pathophysiology of inflammatory bowel disease and its correlation with the degree of inflammation","volume":"12","author":"Patel","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.exer.2021.108825_bib40","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.4049\/jimmunol.131.4.1613","article-title":"Specific stimulation of human T lymphocytes by substance P","volume":"131","author":"Payan","year":"1983","journal-title":"J. Immunol."},{"key":"10.1016\/j.exer.2021.108825_bib41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbmt.2010.08.008","article-title":"Limbus damage in ocular graft-versus-host disease","volume":"17","author":"P\u00e9rez","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.exer.2021.108825_bib42","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbmt.2016.07.012","article-title":"Novel scoring criteria for the evaluation of ocular graft-versus-host disease in a preclinical allogeneic hematopoietic stem cell transplantation animal model","volume":"22","author":"Perez","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.exer.2021.108825_bib43","doi-asserted-by":"crossref","unstructured":"Poe, J.C., Jia, W., Di Paolo, J.A., Reyes, N.J., Kim, J.Y., Su, H., Sundy, J.S., Cardones, A.R., Perez, V.L., Chen, B.J., Chao, N.J., Cardona, D.M., Saban, D.R., Sarantopoulos, S., n.d SYK inhibitor entospletinib prevents ocular and skin GVHD in mice. JCI Insight 3. https:\/\/doi.org\/10.1172\/jci.insight.122430.","DOI":"10.1172\/jci.insight.122430"},{"key":"10.1016\/j.exer.2021.108825_bib44","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.eye.6702052","article-title":"Phenol red thread test vs Schirmer's test: a comparative study","volume":"20","author":"Saleh","year":"2006","journal-title":"Eye"},{"key":"10.1016\/j.exer.2021.108825_bib45","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.3727\/096368915X687480","article-title":"Human bone marrow stromal cells differentiate into corneal tissue and prevent ocular graft-versus-host disease in mice","volume":"24","author":"S\u00e1nchez-Abarca","year":"2015","journal-title":"Cell Transplant."},{"key":"10.1016\/j.exer.2021.108825_bib46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1182\/blood-2018-01-791335","article-title":"Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas","volume":"132","author":"Schmitz","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exer.2021.108825_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12177-008-9006-2","article-title":"Quantitative assessment of tear production: a review of methods and utility in dry eye drug discovery","volume":"1","author":"Senchyna","year":"2008","journal-title":"j ocul biol dis inform"},{"key":"10.1016\/j.exer.2021.108825_bib48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-0716-0845-6_17","article-title":"Murine corneal epithelial wound modeling","volume":"2193","author":"Shah","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.exer.2021.108825_bib49","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.survophthal.2012.08.004","article-title":"Ocular graft-versus-host disease: a review","volume":"58","author":"Shikari","year":"2013","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108825_bib50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/mol.115.101014","article-title":"Substance P enhances keratocyte migration and neutrophil recruitment through interleukin-8","volume":"89","author":"S\u0142oniecka","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.exer.2021.108825_bib51","doi-asserted-by":"crossref","first-page":"C696","DOI":"10.1152\/ajpcell.00060.2007","article-title":"Neuropeptide substance P upregulates chemokine and chemokine receptor expression in primary mouse neutrophils","volume":"293","author":"Sun","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.exer.2021.108825_bib52","doi-asserted-by":"crossref","first-page":"C1586","DOI":"10.1152\/ajpcell.00129.2008","article-title":"Substance P enhances NF-kappaB transactivation and chemokine response in murine macrophages via ERK1\/2 and p38 MAPK signaling pathways","volume":"294","author":"Sun","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.exer.2021.108825_bib53","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.bbmt.2015.05.020","article-title":"Impact of ocular chronic graft-versus-host disease on quality of life","volume":"21","author":"Sun","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.exer.2021.108825_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.beha.2013.10.009","article-title":"Acute graft-versus-host disease: are we close to bringing the bench to the bedside?","volume":"26","author":"Sung","year":"2013","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.exer.2021.108825_bib55","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4049\/jimmunol.1601751","article-title":"Role of Substance P neuropeptide in inflammation, wound healing and tissue homeostasis","volume":"199","author":"Suvas","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.exer.2021.108825_bib56","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s12185-018-2412-8","article-title":"Hematopoietic stem cell transplantation for acute myeloid leukemia","volume":"107","author":"Takami","year":"2018","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.exer.2021.108825_bib57","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/path.4475","article-title":"Glucocorticoids attenuate acute graft-versus-host disease by suppressing the cytotoxic capacity of CD8+ T cells","volume":"235","author":"Theiss-Suennemann","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.exer.2021.108825_bib58","first-page":"4509","article-title":"Acid sphingomyelinase is required for protection of effector memory T cells against glucocorticoid-induced cell death","volume":"187","author":"Tischner","year":"2011","journal-title":"J.I."},{"key":"10.1016\/j.exer.2021.108825_bib59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/08820538.2011.588663","article-title":"Keratoconjunctivitis sicca manifestations in ocular graft versus host disease: pathogenesis, presentation, prevention, and treatment","volume":"26","author":"Townley","year":"2011","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108825_bib60","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0021-5155(02)00617-2","article-title":"Endogenous substance P in corneal epithelial cells and keratocytes","volume":"46","author":"Watanabe","year":"2002","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108825_bib61","first-page":"2622","article-title":"Substance P and its metabolites in normal human tears","volume":"43","author":"Yamada","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108825_bib62","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease \u2014 biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2021.108825_bib63","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00441-018-2922-y","article-title":"Substance P and pain chronicity","volume":"375","author":"Zieglg\u00e4nsberger","year":"2019","journal-title":"Cell Tissue Res."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521003912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521003912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:17:09Z","timestamp":1757999829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483521003912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":63,"alternative-id":["S0014483521003912"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2021.108825","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical neurokinin-1 receptor antagonist Fosaprepitant ameliorates ocular graft-versus-host disease in a preclinical mouse model","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2021.108825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108825"}}